NASDAQ:LAWS
Delisted
Lawson Products Stock News
$50.55
-0.0800 (-0.158%)
At Close: Aug 17, 2022
Lawson Products, Inc. (LAWS) Management on Q1 2022 Results - Earnings Call Transcript
04:55pm, Saturday, 30'th Apr 2022
Lawson Products, Inc. (NASDAQ:LAWS ) Q1 2022 Results Conference Call April 28, 2022 9:00 AM ET Company Participants Steven Hooser - IR Bryan King - Chairman Ron Knutson - EVP and CFO Operator Good mor
Lawson Products (LAWS) Misses Q1 Earnings Estimates
12:45pm, Thursday, 28'th Apr 2022 Zacks Investment Research
Lawson Products (LAWS) delivered earnings and revenue surprises of -12.31% and 7.02%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Constellium (CSTM) Beats Q1 Earnings and Revenue Estimates
11:15am, Wednesday, 27'th Apr 2022 Zacks Investment Research
Constellium (CSTM) delivered earnings and revenue surprises of 411.11% and 0.96%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Lawson Products (LAWS): Strong Industry, Solid Earnings Estimate Revisions
01:44pm, Monday, 21'st Mar 2022 Zacks Investment Research
Lawson Products (LAWS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Lawson Products (LAWS): Strong Industry, Solid Earnings Estimate Revisions
11:17am, Monday, 21'st Mar 2022
Lawson Products (LAWS) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Lawson Products, Inc. (LAWS) CEO Michael DeCata on Q4 2021 Results - Earnings Call Transcript
06:54pm, Thursday, 24'th Feb 2022 Seeking AlphaLawson Products, Inc. (LAWS) CEO Michael DeCata on Q4 2021 Results - Earnings Call Transcript
01:54pm, Thursday, 24'th Feb 2022
Lawson Products, Inc. (LAWS) CEO Michael DeCata on Q4 2021 Results - Earnings Call Transcript
Lawson Products Non-GAAP EPS of $0.52 beats by $0.05, revenue of $102.1M misses by $0.28M
12:32pm, Thursday, 24'th Feb 2022 Seeking Alpha
Lawson Products press release (LAWS): Q4 Non-GAAP EPS of $0.52 beats by $0.05.Revenue of $102.1M (+4.1% Y/Y) misses by $0.28M.
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Alerts Shareholders of Lawson Products, Inc. (LAWS) Investigation
08:51pm, Tuesday, 08'th Feb 2022 Business Wire
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against the Board of Directors of Lawson Products, Inc. ("Lawson" or "the Company") (NASDAQ: LAWS) for possible breaches of fiduciary duty and other violations of state law in connection with the company’s merger with TestEquity and Gexpro Services, portfolio companies of LKCM Headwater Investments. Such investors are encouraged to obtain additional information and assist th
Lawson Products, Inc. to Report Fourth Quarter 2021 Financial Results
12:30pm, Thursday, 03'rd Feb 2022 Business Wire
CHICAGO--(BUSINESS WIRE)--Lawson Products to Report Fourth Quarter 2021 Financial Results
Halper Sadeh LLP Investigates LAWS, VG, SUNS, TACO, SEAC; Shareholders are Encouraged to Contact the Firm
08:56pm, Saturday, 15'th Jan 2022 Kwhen FinanceLawson Products, Houghton Mifflin Harcourt lead postmarket gainers; Rhythm Pharma top...
10:04pm, Friday, 14'th Jan 2022 Seeking Alpha
Gainers: Lawson Products (LAWS) +7%, Houghton Mifflin Harcourt HMHC +5%, Provention Bio (PRVB) +3%, Array Technologies (ARRY) +3%, People''s United Financial (PBCT) +2%.Losers:
Halper Sadeh LLP Investigates CERN, LAWS, TMX, MIME; Shareholders are Encouraged to Contact the Firm
01:52pm, Thursday, 13'th Jan 2022 Benzinga
NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Cerner Corporation (NASDAQ: CERN ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Oracle Corporation for $95.00 per share. If you are a Cerner shareholder, click here to learn more about your rights and options . Lawson Products, Inc. (NASDAQ: LAWS ) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with TestEquity and Gexpro Full story available on Benzinga.com
NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith Reminds Investors of Investigations Related to the Following Companies: Enterprise Diversified, Inc. (OTC - SYTE), Castlight Health, Inc. (NYSE - CSLT), Lawson Products, Inc. (Nasdaq - LAWS)
09:19pm, Wednesday, 05'th Jan 2022 GlobeNewswire
BALA CYNWYD, Pa., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of investigations it is conducting regarding the following companies for possible breaches of fiduciary duty and other violations of federal and state law with respect to proposed acquisition transactions. If you own shares of any of the below-referenced stocks and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire, or Marc L. Ackerman, Esquire at Brodsky & Smith, Two Bala Plaza, Suite 805, Bala Cynwyd, PA 19004, or calling toll free 855-576-4847. There is no cost or financial obligation to you.
Lawson Products Enters Strategic Combination With TestEquity & Gexpro Services
10:33am, Wednesday, 29'th Dec 2021
Lawson Products, Inc. (NASDAQ: LAWS) and Luther King Capital Management Corporation's private investment arm LKCM Headwater Investments entered definitive merger agreements. Under the agreement, Law